Fundz

Mezzion Pharma Raises Nearly $40M To Advance A First-To-Market Treatment Option For Fontan Patients

PRIVATEApr 25, 2023

Amount Raised

$40 Million

Round Type

Funding Round

Fort LeeBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Mezzion Pharma ("Mezzion"), a rare disease focused pharmaceutical company, announced that it has secured nearly $40M USD to fund FUEL-2, their confirmatory phase 3 clinical trial, along with future commercialization and regulatory submissions in other countries including Europe.

Quick answer

Mezzion Pharma raised $40 Million in a Funding Round round, dated April 25, 2023. Mezzion Pharma is based in Fort Lee, New Jersey, United States.

How much did Mezzion Pharma raise?
Mezzion Pharma raised $40 Million in a Funding Round round on April 25, 2023.
What does Mezzion Pharma do?
Mezzion Pharmaceuticals, Inc., a U.S.-based subsidiary of Mezzion Pharma Co., Ltd. (KOSDAQ: 140410), is a late-stage biopharmaceutical company focused on developing therapies for rare and underserved diseases.
Where is Mezzion Pharma based and how big is it?
Mezzion Pharma is based in Fort Lee, New Jersey, United States.
Who are the decision-makers at Mezzion Pharma?
Fundz holds 1 contact at Mezzion Pharma. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Mezzion Pharma that raised within 45 days of this round, from Fundz verified event records.

Who to call at Mezzion Pharma, and when

A new round usually means Mezzion Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mezzion Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mezzion Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mezzion Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mezzion Pharma

Location

Fort Lee, New Jersey, United States

About

Mezzion Pharmaceuticals, Inc., a U.S.-based subsidiary of Mezzion Pharma Co., Ltd. (KOSDAQ: 140410), is a late-stage biopharmaceutical company focused on developing therapies for rare and underserved diseases. Mezzion is advancing JURVIGO® (udenafil) through a global Phase 3 clinical program as a potential first-in-class therapy for patients with single ventricle congenital heart disease and Fontan physiology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mezzion Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Mezzion Pharma's next move

See what Strategic adds

Mezzion Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.